三种列线图在扩展和/或前哨淋巴结清扫的前列腺癌患者中预测淋巴结侵犯概率的验证与头对头比较
该回顾性研究纳入1183例接受机器人辅助腹腔镜根治性前列腺切除术联合盆腔淋巴结清扫的局限期前列腺癌患者和224例接受前哨淋巴结清扫联合外照射放疗的患者,外部验证Winter列线图并与MSKCC和更新版Briganti列线图比较。在ePLND+SNB组和sLND组中Winter列线图预测淋巴结侵犯的AUC最佳,分别为0.735和0.709;在ePLND组中Briganti列线图AUC为0.756,优于MSKCC的0.744和Winter的0.746。所有列线图在低/中危患者中准确性更好,在高危人群中均高估淋巴结侵犯风险。
要点
- Winter列线图在ePLND+SNB组(AUC 0.735)和sLND组(AUC 0.709)中预测淋巴结侵犯最佳。
- ePLND组中Briganti列线图AUC为0.756,优于MSKCC的0.744和Winter的0.746。
- 所有列线图在低/中危患者中准确性更好,在高危人群中高估淋巴结侵犯风险。
核心结论
- 基于前哨淋巴结的更新版Winter列线图在前哨淋巴结人群中预测效果更好。
- 其结果与基于(e)PLND开发的预测工具相当,提示SNB与非SNB之间采样准确性存在差异。
- 从列线图获益最大的患者是淋巴结转移低/中危者。
研究设计与样本
- 回顾性研究,纳入1183例接受机器人辅助腹腔镜根治性前列腺切除术联合盆腔淋巴结清扫的局限期前列腺癌患者。
- 另纳入224例接受前哨淋巴结清扫联合外照射放疗、仅在前哨淋巴结组织学阳性时行盆腔放疗的患者。
- 在RARP人群中,956例(80.8%)接受ePLND,227例(19.2%)接受ePLND联合额外SNB。
- 外部验证Winter列线图,并与MSKCC和更新版Briganti列线图进行头对头比较。
主要发现
- ePLND组、ePLND+SNB组和sLND组切除淋巴结中位数分别为10枚(IQR 6-14)、15枚(IQR 10-20)和7枚(IQR 4-10)。
- ePLND组、ePLND+SNB组和sLND组淋巴结侵犯率分别为16.6%、25.5%和42%。
- ePLND组中Briganti列线图AUC为0.756,优于MSKCC的0.744和Winter的0.746。
- ePLND+SNB组中Winter列线图AUC为0.735,sLND组中Winter列线图AUC为0.709,均为该人群最佳预测工具。
- 校准分析中所有列线图在低/中危患者中准确性更好,在高危人群中观察到对淋巴结侵犯风险的高估。
关键数值与推荐
- ePLND组AUC:Briganti 0.756、Winter 0.746、MSKCC 0.744。
- ePLND+SNB组AUC:Winter 0.735为最佳。
- sLND组AUC:Winter 0.709为最佳。
- ePLND组淋巴结侵犯率16.6%,ePLND+SNB组25.5%,sLND组42%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The updated Winter nomogram is the only nomogram predicting lymph node invasion (LNI) in prostate cancer (PCa) patients based on sentinel node (SN) dissection (sLND). The aim of the study was to externally validate the Winter nomogram and examine its performance in patients undergoing extended pelvic lymph node dissection (ePLND), ePLND combined with SN biopsy (SNB) and sLND only. The results were compared with the Memorial Sloan Kettering Cancer Center (MSKCC) and updated Briganti nomograms. METHODS: This retrospective study included 1183 patients with localized PCa undergoing robot-assisted laparoscopic radical prostatectomy (RARP) combined with pelvic lymphadenectomy and 224 patients treated with sLND and external beam radiotherapy (EBRT), aiming to offer pelvic radiotherapy only in case of histologically positive SNs. In the RARP population, ePLND was applied in 956 (80.8%) patients,while 227 (19.2%) patients were offered ePLND combined with additional SNB. RESULTS: The median numbers of removed nodes were 10 (interquartile range, IQR = 6-14), 15 (IQR = 10-20) and 7 (IQR = 4-10) in the ePLND, ePLND + SNB, and sLND groups, respectively. Corresponding LNI rates were 16.6%, 25.5% and 42%. Based on the AUC, the performance of the Briganti nomogram (0.756) in the ePLND group was superior to both the MSKCC (0.744) and Winter nomogram (0.746). The Winter nomogram, however, was the best predictor of LNI in both the ePLND + SNB (0.735) and sLND (0.709) populations. In the calibration analysis, all nomograms showed better accuracy in the low/intermediate risk patients, while in the high-risk population, an overestimation of the risk for LNI was observed. CONCLUSION: The SN-based updated nomogram showed better prediction in the SN population. The results were also comparable, relative to predictive tools developed with (e)PLND, suggesting a difference in sampling accuracy between SNB and non-SNB. Patients who benefit most from the nomogram would be those with a low/intermediate risk of LN metastasis.
引用
- Grivas N, Wit E, Tillier C, et al. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection. Eur J Nucl Med Mol Imaging. 2017. PMID: 28780722. doi:10.1007/s00259-017-3788-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。